Review
The Cellular Metabolism and Systemic Toxicity of Arsenic

https://doi.org/10.1006/taap.2001.9258Get rights and content

Abstract

Although it has been known for decades that humans and many other species convert inorganic arsenic to mono- and dimethylated metabolites, relatively little attention has been given to the biological effects of these methylated products. It has been widely held that inorganic arsenicals were the species that accounted for the toxic and carcinogenic effects of this metalloid and that methylation was properly regarded as a mechanism for detoxification of arsenic. Elucidation of the metabolic pathway for arsenic has changed our understanding of the significance of methylation. Both methylated and dimethylated arsenicals that contain arsenic in the trivalent oxidation state have been identified as intermediates in the metabolic pathway. These compounds have been detected in human cells cultured in the presence of inorganic arsenic and in urine of individuals who were chronically exposed to inorganic arsenic. Methylated and dimethylated arsenicals that contain arsenic in the trivalent oxidation state are more cytotoxic, more genotoxic, and more potent inhibitors of the activities of some enzymes than are inorganic arsenicals that contain arsenic in the trivalent oxidation state. Hence, it is reasonable to describe the methylation of arsenic as a pathway for its activation, not as a mode of detoxification. This review summarizes the current knowledge of the processes that control the formation and fate of the methylated metabolites of arsenic and of the biological effects of these compounds. Given the considerable interest in the dose–response relationships for arsenic as a toxin and a carcinogen, understanding the metabolism of arsenic may be critical to assessing the risk associated with chronic exposure to this element.

References (182)

  • H.Y. Chiou et al.

    Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and M2 among current arsenic-exposed residents of Taiwan

    Mutat. Res.

    (1997)
  • G. Concha et al.

    Exposure to inorganic arsenic metabolites during early human development

    Toxicol. Sci.

    (1998)
  • W.R. Cullen et al.

    The reduction of trimethylarsine oxide to trimethylarsine by thiols: A mechanistic model for the biological reduction of arsenicals

    J. Inorg. Biochem.

    (1984)
  • M. Delnomdedieu et al.

    Reduction and binding of arsenate and dimethylarsenate by glutathione: A multinuclear magnetic resonance study

    Chem.–Biol. Interact.

    (1994)
  • M. Delnomdedieu et al.

    Time dependence of accumulation and binding of inorganic and organic arsenic species in rabbit erythrocytes

    Chem.–Biol. Interact.

    (1995)
  • J.M. DeSesso et al.

    An assessment of the developmental toxicity of inorganic arsenic

    Reprod. Toxicol.

    (1998)
  • S.M. Healy et al.

    Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsenic in the guinea pig

    Mutat. Res.

    (1997)
  • S.M. Healy et al.

    Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice

    Toxicol. Appl. Pharmacol.

    (1998)
  • C. Hopenhayn-Rich et al.

    Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic

    Environ. Res.

    (1993)
  • Y.M. Hsueh et al.

    Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure

    Atherosclerosis

    (1998)
  • M.F. Hughes et al.

    Strain-dependent disposition of inorganic arsenic in the mouse

    Toxicology

    (1999)
  • M.F. Hughes et al.

    Dose-dependent effects on tissue distribution and metabolism of dimethylarsinic acid in the mouse after intravenous administration

    Toxicology

    (2000)
  • K.T. Kitchin

    Recent advances in arsenic carcinogenesis: Modes of action, animal model systems and methylated arsenic metabolites

    Toxicol. Appl. Pharmacol.

    (2001)
  • H.Z. Ma et al.

    Human exposure to arsenic and health effects in Bayingnormen, Inner Mongolia

  • E. Marafante et al.

    Intracellular interaction and biotransformation of arsenite in rats and rabbits

    Sci. Total Environ.

    (1982)
  • E. Marafante et al.

    The effect of methyltransferase inhibition on the metabolism of [74As] arsenite in mice and rabbits

    Chem.–Biol. Interact.

    (1984)
  • H. Ahsan et al.

    Associations of drinking water and urinary arsenic levels and skin lesions in Bangladesh

    J. Occup. Environ. Med.

    (2000)
  • H.V. Aposhian et al.

    Enzymatic methylation of arsenic compounds: II—An overview

  • H.V. Aposhian

    Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity

    Annu. Rev. Pharmacol. Toxicol.

    (1997)
  • H.V. Aposhian et al.

    DMPS-arsenic challenge test. I. Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate

    J. Pharmacol. Exp. Ther.

    (1997)
  • H.V. Aposhian et al.

    Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic

    Chem. Res. Toxicol.

    (2000)
  • A.S. Baldwin

    The transcription factor NF-κB and human disease

    J. Clin. Invest.

    (2001)
  • M.N. Bates et al.

    Arsenic ingestion and internal cancers: A review

    Am. J. Epidemiol.

    (1992)
  • M.N. Bates et al.

    Case-control study of bladder cancer and arsenic in drinking water

    Am. J. Epidemiol.

    (1995)
  • L. Benramdane et al.

    Arsenic speciation in human organs following fatal arsenic trioxide poisoning: A case report

    Clin. Chem.

    (1999)
  • M. Börzsönyi et al.

    Epidemiological studies on human subjects exposed to arsenic in drinking water in Southeast Hungary

    Arch. Toxicol.

    (1992)
  • J.P. Buchet et al.

    The influence of liver disease on the methylation of arsenite in humans

    Arch. Toxicol.

    (1984)
  • J.P. Buchet et al.

    Study of inorganic arsenic methylation by rat in vitro: Relevance for the interpretation of observations in man

    Arch. Toxicol.

    (1985)
  • G.S. Buzard et al.

    Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis: A review

    J. Environ. Pathol. Toxicol. Oncol.

    (2000)
  • D.M. Byrd et al.

    Carcinogenic risks of inorganic arsenic in perspective

    Int. Arch. Occup. Environ. Health

    (1996)
  • M.E. Cebrian et al.

    Chronic arsenic poisoning in the north of Mexico

    Hum. Toxicol.

    (1983)
  • T.C. Chang et al.

    Higher prevalence of goiter in endemic area of blackfoot disease of Taiwan

    J. Formos. Med. Assoc.

    (1991)
  • C.J. Chen et al.

    Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High arsenic artesian well water and cancers

    Cancer Res.

    (1985)
  • C.J. Chen et al.

    Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water

    Br. J. Cancer

    (1992)
  • C.J. Chen et al.

    Increased prevalence of hypertension and long-term arsenic exposure

    Hypertension

    (1995)
  • C.J. Chen et al.

    Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure

    Arterioscler. Thromb. Vasc. Biol.

    (1996)
  • H.-S. Chiang et al.

    Comparative study of the high prevalence of bladder cancer in the Blackfoot disease endemic area of Taiwan

    J. Formos. Med. Assoc.

    (1988)
  • H.-Y. Chiou et al.

    Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study

    Cancer Res.

    (1995)
  • H.-Y. Chiou et al.

    Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic

    Stroke

    (1997)
  • J.J. Chisolm et al.

    Developmental toxicity of metals—Implications for public health

  • Cited by (0)

    Disclaimer—This manuscript has been reviewed in accordance with the policy of the Health Effects Research Laboratory, U.S. Environmental Protection Agency, and approved for publication. Approval does not signify that the contents necessarily reflect the views and policies of the Agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.

    2

    To whom correspondence should be addressed at MD 74, NHEERL, ORD, U.S. EPA, Research Triangle Park, NC 27711. E-mail: [email protected].

    View full text